X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6) 6
humans (4) 4
oncology (4) 4
apoptosis (3) 3
cell lung-cancer (3) 3
ipilimumab (3) 3
lung cancer (3) 3
melanoma (3) 3
pembrolizumab (3) 3
pharmacokinetics (3) 3
animals (2) 2
antibodies, monoclonal, humanized - blood (2) 2
cancer (2) 2
chemotherapy (2) 2
efficacy (2) 2
female (2) 2
male (2) 2
metabolism (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
patients (2) 2
pharmacology (2) 2
research (2) 2
research article (2) 2
adolescent (1) 1
adult (1) 1
advanced melanoma (1) 1
advanced solid tumors (1) 1
advanced tumors (1) 1
aged (1) 1
aged, 80 and over (1) 1
analysis (1) 1
angiotensin ii type 1 receptor blockers - therapeutic use (1) 1
angiotensin-converting enzyme inhibitors - therapeutic use (1) 1
angiotensin-ii receptor (1) 1
aniline compounds - pharmacology (1) 1
animal models (1) 1
antiangiogenesis therapy (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - pharmacokinetics (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
anticancer properties (1) 1
antihypertensive agents - therapeutic use (1) 1
antineoplastic agents - blood (1) 1
antineoplastic agents - pharmacokinetics (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents, immunological - administration & dosage (1) 1
antineoplastic agents, immunological - blood (1) 1
antineoplastic agents, immunological - therapeutic use (1) 1
antitumor activity (1) 1
apoptosis - drug effects (1) 1
apoptosis - genetics (1) 1
arterial-pressure (1) 1
b7-h1 (1) 1
basic cancer research (1) 1
bcl-x protein (1) 1
bcl-x protein - genetics (1) 1
bcl-x protein - metabolism (1) 1
best overall response (1) 1
biochemistry, general (1) 1
bioinformatics (1) 1
biology and life sciences (1) 1
biomarkers (1) 1
biomedical engineering (1) 1
biomedicine (1) 1
blood pressure (1) 1
blood pressure - drug effects (1) 1
blood-pressure regulation (1) 1
body weight (1) 1
bridged bicyclo compounds, heterocyclic - pharmacology (1) 1
calcium channel blockers - therapeutic use (1) 1
cancer drug discovery (1) 1
cancer treatment (1) 1
carcinoma (1) 1
carcinoma, non-small-cell lung - blood (1) 1
care and treatment (1) 1
cell biology (1) 1
cell cycle (1) 1
cell cycle and cell division (1) 1
cell cycle checkpoints - drug effects (1) 1
cell cycle checkpoints - genetics (1) 1
cell cycle inhibitors (1) 1
cell death (1) 1
cell line, tumor (1) 1
cell processes (1) 1
cells (1) 1
chronic lymphocytic-leukemia (1) 1
clinical dose (1) 1
clinical trials as topic - statistics & numerical data (1) 1
combination therapy (1) 1
computer simulation (1) 1
cycle (1) 1
data analysis (1) 1
dependent kinase inhibitor (1) 1
disease control (1) 1
disease models, animal (1) 1
diterpenes - pharmacology (1) 1
diuretics - therapeutic use (1) 1
dose-response relationship, drug (1) 1
dosing strategy (1) 1
double-blind (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 12/2018, Volume 24, Issue 23, pp. 5841 - 5849
Purpose: To investigate the relationship of pembrolizumab pharmacokinetics (PK) and overall survival (OS) in patients with advanced melanoma and non-small cell... 
CELL LUNG-CANCER | MELANOMA | ONCOLOGY | METABOLISM | POPULATION PHARMACOKINETICS | PHASE-II | TUMOR SIZE | PREDICT SURVIVAL | IPILIMUMAB | CHEMOTHERAPY
Journal Article
Journal of Pharmacokinetics and Pharmacodynamics, ISSN 1567-567X, 10/2017, Volume 44, Issue 5, pp. 403 - 414
Journal Article
Journal for immunotherapy of cancer, ISSN 2051-1426, 08/2019, Volume 7, Issue 1, pp. 212 - 8
Pembrolizumab is a potent, humanized, monoclonal anti-programmed death 1 antibody that has demonstrated effective antitumor activity and acceptable safety in... 
Immunogenetics | Research | Gene expression | Apoptosis | Efficacy | Advanced tumors | Pembrolizumab | Treatment-emergent ADA | Safety | Immunogenicity
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e108371
Dinaciclib is a potent CDK1, 2, 5 and 9 inhibitor being developed for the treatment of cancer. Additional understanding of antitumor mechanisms and... 
CELL LUNG-CANCER | FAMILY INHIBITOR | XENOGRAFT MODELS | POTENT | MECHANISM | MULTIDISCIPLINARY SCIENCES | CHRONIC LYMPHOCYTIC-LEUKEMIA | MALIGNANCIES | DEPENDENT KINASE INHIBITOR | SCH 727965 | CYCLE | Neoplasms - metabolism | Apoptosis - drug effects | Humans | Myeloid Cell Leukemia Sequence 1 Protein - metabolism | bcl-X Protein - genetics | Apoptosis - genetics | Male | RNA, Messenger - metabolism | Epoxy Compounds - pharmacology | Neoplasms - genetics | Cell Cycle Checkpoints - genetics | Female | Antineoplastic Agents - pharmacology | Disease Models, Animal | Diterpenes - pharmacology | Aniline Compounds - pharmacology | RNA, Messenger - genetics | Gene Dosage | Sulfonamides - pharmacology | Myeloid Cell Leukemia Sequence 1 Protein - genetics | Drug Synergism | Xenograft Model Antitumor Assays | Phenanthrenes - pharmacology | Pyridinium Compounds - pharmacology | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Cell Cycle Checkpoints - drug effects | Cell Line, Tumor | Mice | bcl-X Protein - metabolism | RNA | Analysis | Tumors | Apoptosis | Animal models | Laboratories | Lung cancer | Oncology | mRNA | Vaccines | Kinases | Anticancer properties | Proteins | Bcl-x protein | Cell cycle | Mathematical models | Bioinformatics | Pharmacology | RNA polymerase | Metabolism | Mcl-1 protein | Inhibitors | Response rates | Biomarkers | Antitumor activity | Lymphomas | In vivo methods and tests | Product development | Mutation | Kinetics | Solid tumors | Pharmacokinetics | Cancer
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 05/2014, Volume 306, Issue 9, pp. R647 - R662
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.